Terms: = Pancreatic cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
39 results:
1. Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy.
Horvat NK; Karpovsky I; Phillips M; Wyatt MM; Hall MA; Herting CJ; Hammons J; Mahdi Z; Moffitt RA; Paulos CM; Lesinski GB
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38191243
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of the distance from the root of splenic artery to tumor in the patients with pancreatic body or tail cancer.
Minagawa T; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Sasaki K; Uesaka K
Pancreatology; 2024 Feb; 24(1):100-108. PubMed ID: 38102055
[TBL] [Abstract] [Full Text] [Related]
3. Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.
Kumar V; Mahato RI
Cancer Lett; 2023 Nov; 579():216462. PubMed ID: 37924937
[TBL] [Abstract] [Full Text] [Related]
4. Modified Appleby procedure for locally advanced pancreatic carcinoma: A primer for the radiologist.
Sindayigaya R; Barat M; Tzedakis S; Dautry R; Dohan A; Belle A; Coriat R; Soyer P; Fuks D; Marchese U
Diagn Interv Imaging; 2023 Oct; 104(10):455-464. PubMed ID: 37301694
[TBL] [Abstract] [Full Text] [Related]
5. C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Shirakawa T; Makiyama A; Shimokawa M; Otsuka T; Shinohara Y; Koga F; Ueda Y; Nakazawa J; Otsu S; Komori A; Arima S; Fukahori M; Taguchi H; Honda T; Shibuki T; Nio K; Ide Y; Ureshino N; Mizuta T; Mitsugi K; Akashi K; Baba E
Sci Rep; 2023 May; 13(1):8815. PubMed ID: 37258608
[TBL] [Abstract] [Full Text] [Related]
6. Progress and prospects for use of cellular immunotherapy in pancreatic cancer.
Tian J; Bai T; Zhang Z; Zhai X; Wang K; Gao X; Yan B
J Cancer Res Ther; 2022 Dec; 18(7):1867-1875. PubMed ID: 36647944
[TBL] [Abstract] [Full Text] [Related]
7. Association between the Preoperative
Funamizu N; Sogabe K; Shine M; Honjo M; Sakamoto A; Nishi Y; Matsui T; Uraoka M; Nagaoka T; Iwata M; Ito C; Tamura K; Sakamoto K; Ogawa K; Takada Y
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558435
[TBL] [Abstract] [Full Text] [Related]
8. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
Rémond MS; Pellat A; Brezault C; Dhooge M; Coriat R
ESMO Open; 2022 Dec; 7(6):100638. PubMed ID: 36399952
[TBL] [Abstract] [Full Text] [Related]
9. Advances in car T-cell therapy in bile duct, pancreatic, and gastric cancers.
Feng Q; Sun B; Xue T; Li R; Lin C; Gao Y; Sun L; Zhuo Y; Wang D
Front Immunol; 2022; 13():1025608. PubMed ID: 36341440
[TBL] [Abstract] [Full Text] [Related]
10. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
11. Recent Advances in IL-13Rα2-Directed cancer Immunotherapy.
Knudson KM; Hwang S; McCann MS; Joshi BH; Husain SR; Puri RK
Front Immunol; 2022; 13():878365. PubMed ID: 35464460
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.
Asakura R; Yanagimoto H; Ajiki T; Tsugawa D; Mizumoto T; So S; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Kuramitsu K; Goto T; Asari S; Kido M; Toyama H; Fukumoto T
Dig Surg; 2022; 39(2-3):65-74. PubMed ID: 35051946
[TBL] [Abstract] [Full Text] [Related]
13. The Landscape Of Alpha Fetoprotein In Hepatocellular carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract] [Full Text] [Related]
14. Longitudinal Analysis of Human pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures.
Kim J; Ekstrom T; Yang W; Donahue G; Grygoryev D; Ngo TTM; Muschler JL; Morgan T; Zaret KS
Mol Cancer Res; 2021 Nov; 19(11):1854-1867. PubMed ID: 34330844
[TBL] [Abstract] [Full Text] [Related]
15. Distal pancreatectomy with En bloc celiac axis resection for locally advanced pancreatic body/tail cancer: A systematic review and meta-analysis.
Liu L; Liu TX; Huang WX; Yang Z; Wang S; Da MX; Dong Y
Asian J Surg; 2022 Jan; 45(1):51-61. PubMed ID: 34187724
[TBL] [Abstract] [Full Text] [Related]
16. Oncolytic adeno-immunotherapy modulates the immune system enabling car T-cells to cure pancreatic tumors.
Rosewell Shaw A; Porter CE; Yip T; Mah WC; McKenna MK; Dysthe M; Jung Y; Parihar R; Brenner MK; Suzuki M
Commun Biol; 2021 Mar; 4(1):368. PubMed ID: 33742099
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.
Noguchi D; Kuriyama N; Nakagawa Y; Maeda K; Shinkai T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kishiwada M; Sakurai H; Mizuno S
PLoS One; 2021; 16(1):e0245946. PubMed ID: 33507925
[TBL] [Abstract] [Full Text] [Related]
18. The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection.
van Wijk L; de Klein GW; Kanters MA; Patijn GA; Klaase JM
Eur J Med Res; 2020 Oct; 25(1):46. PubMed ID: 33028394
[TBL] [Abstract] [Full Text] [Related]
19. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract] [Full Text] [Related]
20. From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in pancreatic Ductal Adenocarcinoma.
Montemagno C; Cassim S; Pouyssegur J; Broisat A; Pagès G
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517181
[TBL] [Abstract] [Full Text] [Related]
[Next]
